Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This should be a beast today! You’ll want shares or you can watch from the sidelines…
stock is increasing close to 48% ahead of its earnings report tomorrow.
Nice seeing after hour action today was nice, hopefully some big news on the way, and let’s clear them shorts out! Id like to see $2+
Thanks for keep us info.
South Korea reports record high 383,665 new COVID-19 cases https://www.reuters.com/world/asia-pacific/south-korea-reports-record-high-383665-new-covid-19-cases-kdca-2022-03-12/
Covid-19 cases continue to rise in China's worst outbreak since Wuhan
https://www.cnn.com/2022/03/14/china/china-covid-outbreak-monday-intl-hnk/index.html
China’s Covid-19 Surge Shuts Down Plants in Manufacturing Hubs Shenzhen and Changchun
https://www.wsj.com/articles/covid-19-outbreak-shuts-down-some-china-factories-including-apple-supplier-11647246503
$CEMI China's new COVID lockdown hits Apple supplier, raising risk of higher inflation
https://www.foxbusiness.com/economy/china-covid-lockdown-apple-automakers-inflation
$CEMI has $28.77M in cash
**Covid testing** $CEMI Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as sells its products directly through distributors to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York. https://finance.yahoo.com/quote/CEMI/profile?p=CEMI
$CEMI Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, Hepatitis C, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, Rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as under the private labels of its marketing partners to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York.
https://finance.yahoo.com/quote/CEMI/profile?p=CEMI
Chembio Diagnostics CEMI recently received SAHPRA approval for the DPP SARS-CoV-2 antigen test.
They said need more samples and resubmit it .. I would hold .. why take a loss .. this will bounce again .. that advice is how you lose money !
ouch. better to sell before under 1.00. FDA just rejected it.
8-k - FDA REJECTS EUA for their DPP Respiratory test.
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001092662/000114036121043264/brhc10032317_8k.htm
8-k - FDA REJECTS EUA for their DPP Respiratory test.
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001092662/000114036121043264/brhc10032317_8k.htm
CEMI - Tuesday Rundown, Wednesday Expectations
Fully loaded 2.00 waiting for EUA announce
Not in it now but doubt you see that .. it will probably bounce off these lows .. I’ll jump in if it gets down to two
Under $1.00 $CEMI coming
Think this is getting ready to move shortly.. earnings come out November fourth.. should be pretty good ! Cemi $$$$$$$
Thanks I know what they do and make, you can call the number in the job ad and talk to investors relations. They will talk to you and explain in detail and will thank you for supporting them. I'm just a small guy with 2200 shares. I wish it would jump soon but it doesn't matter im good
$CEMI Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, Hepatitis C, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, Rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as under the private labels of its marketing partners to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York.
CEMI
Biden has announced a new plan for COVID-19
— Chembio Diagnostics, Inc. (@ChembioDx) September 17, 2021
Employers with 100+ workers will now require vaccines or weekly testing
Chembio provides tests for Symptomatic & Asymptomatic serial testing, as well as multiplex COVID/Flu testing
Find out more here: https://t.co/xe4tYHwn8N pic.twitter.com/NEENcXLdXW
Two catalysts are going to impact stock move higher. EUA and earnings.
CEMI Chembio Diagnostics recently Received $4 Million HIV Test Purchase Order Supported by The Global Fund The HIV 1/2 STAT-PAK Assay is a World Health Organization (WHO) prequalified, rapid point-of-care assay for the detection of HIV-1 and HIV-2 antibodies in fingerstick whole blood, venous whole blood, serum, or plasma.
CEMI On average, analysts give Chembio Diagnostics Inc a Buy rating. The average price target is $10, which means analysts expect the stock to climb by 250.88% over the next twelve months. That average ranking earns Chembio Diagnostics Inc an Analyst Rating of 29, which is better than 29% of stocks based on data compiled by InvestorsObserver.
Nice, hopefully it's sooner than later. Been stuck here since they're last earnings report
Nice, hopefully it's sooner than later. Been stuck here since they're last earnings report
$CEMI soon:))) FDA EUA approval.
Let's not forget:))) This was $12.7 million contract awarded therefore, I think they will push for the approval.
"The DPP Respiratory Antigen Panel test system was developed with funds and support as part of a $12.7 million contract awarded by Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services.
https://www.yahoo.com/now/chembio-announces-eua-submission-dpp-120000803.html
Unfortunately that one has been tainted by it's management toxic insider selling and other issues.
$CEMI Super LOW Float 26.92M
$CEMI COVID-19 vaccines kept more than 100,000 U.S. seniors out of hospital, and WHO warns, ‘we are not out of the woods yet’
https://finance.yahoo.com/m/8b46efd6-5aee-3acf-910f-ec58bab6f62f/covid-19-vaccines-kept-more.html
GM all, liking that 8.00 forecast
https://money.cnn.com/quote/forecast/forecast.html?symb=cemi
$CEMI
$CEMI
The search for a really effective Covid vaccine is still on. Lots of opportunity for rapid testing, antibody tests and vaccines that last longer.
$CEMI The global market for #Covid_19 diagnostic services market should grow from $84.4 billion in 2021 to $195.1 billion by 2027, at a compound annual growth rate (CAGR) of 15.0% during 2021-2027. https://www.bccresearch.com/market-research/medical-devices-and-surgical/covid-19-diagnostics-market-report.html
Covid19 testing. Employers might face an OSHA penalty of up to $14,000 for violations.
https://www.wesa.fm/health-science-tech/2021-09-15/bidens-mandate-requires-weekly-covid-19-testing-for-unvaccinated-employees-that-will-get-expensive $CEMI
$CEMI $8.00 / 12-month price forecasts for Chembio Diagnostics Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +243.35% increase from the last price of 2.33. https://money.cnn.com/quote/forecast/forecast.html?symb=cemi
$CEMI Biden's Mandate Requires Weekly COVID-19 Testing For Unvaccinated Employees. That Will Get Expensive.
https://www.wesa.fm/health-science-tech/2021-09-15/bidens-mandate-requires-weekly-covid-19-testing-for-unvaccinated-employees-that-will-get-expensive
-.09 on only 397,827 volume. Fake
$CEMI HIV Diagnostics Market Revenue to Cross USD $760 Mn by 2027
$CEMI Top Mutual Fund Holders
Holder Shares Date Reported % Out Value
Vanguard Total Stock Market Index Fund 546,834 Jun 29, 2021 1.91% 1,624,096
Vanguard Extended Market Index Fund 288,247 Jun 29, 2021 1.01% 856,093
Royce Micro-Cap Fund 240,253 Jun 29, 2021 0.84% 713,551
Segall Bryant & Hamill Small Cap Value Fd 185,625 Jun 29, 2021 0.65% 551,306
Royce Micro Cap Trust 135,800 Jun 29, 2021 0.47% 403,326
Royce Capital Fund-Micro-Cap Portfolio 107,400 Jun 29, 2021 0.38% 318,978
Columbia Fds Var Ser Tr II-Var Port-Partners Small Cap Value Fd 101,923 Jun 29, 2021 0.36% 302,711
Fidelity Extended Market Index Fund 89,642 Jul 30, 2021 0.31% 254,583
Vanguard Russell 2000 Index Fund 42,471 May 30, 2021 0.15% 135,482
iShares Micro Cap ETF 38,760 Aug 30, 2021 0.14% 106,202
https://finance.yahoo.com/quote/CEMI/holders?p=CEMI
Followers
|
41
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1166
|
Created
|
02/14/06
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |